Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $107.7500 (-3.42%) ($107.6600 - $112.6400) on Fri. Apr. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 46 | Latest Price | $107.7500(-3.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.6% a day on average for past five trading days. | Weekly Trend | LGND declines -0.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(59%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.795% in a week (0% probabilities). VIXM(-25%) UUP(-20%) VXX(-16%) TBT(-8%) EDOC(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $112.28 | 5 Day Moving Average | $112.41(-4.15%) | 10 Day Moving Average | $114.08(-5.55%) | 20 Day Moving Average | $112.28(-4.03%) | To recent high | -26.6% | To recent low | 13% | Market Cap | $1.732b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |